access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
This randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men with prostate cancer that has spread to other places in the body (metastatic) and has become resistant to testosterone-deprivation therapy (castration-resistant).
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.